Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Low Dose Emicizumab and Low Dose Factor VIII as a Prophylaxis in Hemophilia A Patients- a Randomized Control Trial'

NCT06938659 is registered in ClinicalTrials.gov with Dhaka Medical College as lead sponsor.

NCT NCT06938659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06938659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Low Dose Emicizumab and Low Dose Factor VIII as a Prophylaxis in Hemophilia A Patients- a Randomized Control Trial'
Lead sponsor
Dhaka Medical College
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
June 1, 2025
Completion date
July 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a